| Financial Year |
March 31 2023 |
| Monetary Funds |
1,601,835,881.94 |
| Held-for-trading Financial Assets |
115,070,966.92 |
| Notes Receivable |
5,097,211.17 |
| Accounts Receivable |
2,993,185,628.14 |
| Advances to Suppliers |
186,523,798.19 |
| Other Receivables |
35,807,230.05 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
1,623,767,777.82 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
6,257,828.06 |
| Total Current Assets |
7,161,102,457.52 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
41,783,021.34 |
| Investment Properties |
18,391,296.14 |
| Fixed Assetes |
1,723,276,221.01 |
| Under-construction Projects |
165,473,049.38 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
320,469,770.19 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
11,545,814.75 |
| Deferred Income Tax Assets |
71,281,428.04 |
| Other Non-Current Assets |
90,579,849.37 |
| Sub-Total of Non-Current Assets |
2,465,851,791.15 |
| Total Assets |
9,626,954,248.67 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
1,018,731,797.51 |
| Accounts Payable |
817,375,871.61 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
23,736,221.60 |
| Taxes Payable |
77,071,241.64 |
| Interest Payable |
-- |
| Dividend Payable |
171,928,842.00 |
| Other payables |
190,819,858.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
6,950,330.49 |
| Other Current Liabilities |
70,316,678.56 |
| Sub-Total of Current Liabilities |
2,762,348,447.05 |
| Long-term Loans |
1,060,901,694.44 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
8,502,700.00 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
45,702,435.40 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
1,252,395,856.52 |
| Total Liabilities |
4,014,744,303.57 |
| Paid-In Capital(Or Share Stock) |
687,715,368.00 |
| Capital Surplus |
1,304,463,870.77 |
| Surplus Reserve |
417,220,254.24 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
3,114,094,616.01 |
| Minority Stockholder's Interest |
-- |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,612,209,945.10 |
| Owner's Equity（Stockholder's Equity） |
5,612,209,945.10 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
9,626,954,248.67 |
